Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

By afschroeder • October 14, 2025

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer. Sci Rep. 2025 Oct 13;15(1):35597. doi: 10.1038/s41598-025-11897-9. PMID: 41083501.

Tags: Cedars Sinai DoM, Dermatology, Harbor UCLA, Hematology/Oncology, Lung adenocarcinoma, NMT1, Publications, survival, The Cancer Genome Atlas, TIMM17A

Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity

Li YR, Shen X, Zhu Y, Li Z, Hon R, Tian Y, Huang J, Zhao AS, Ma NY, Zhang C, Lin D, Sargsyan K, Yuan[...]

Opportunistic Screening of Chronic Liver Disease with Deep-Learning-Enhanced Echocardiography

Sahashi Y, Vukadinovic M, Amrollahi F, Trivedi H, Rhee J, Chen J, Cheng S, Ouyang D, Kwan AC. Opportunistic Screening of Chronic Liver Disease with[...]

Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination

Bower JE, Radin A, Ganz PA, Irwin MR, Cole SW, Petersen L, Asher A, Hurvitz SA, Crespi CM. Inflammation and dimensions of fatigue in women[...]